336 related articles for article (PubMed ID: 18728184)
21. Genetics and molecular pathology of Stargardt-like macular degeneration.
Vasireddy V; Wong P; Ayyagari R
Prog Retin Eye Res; 2010 May; 29(3):191-207. PubMed ID: 20096366
[TBL] [Abstract][Full Text] [Related]
22. ELOVL4: Very long-chain fatty acids serve an eclectic role in mammalian health and function.
Hopiavuori BR; Anderson RE; Agbaga MP
Prog Retin Eye Res; 2019 Mar; 69():137-158. PubMed ID: 30982505
[TBL] [Abstract][Full Text] [Related]
23. Dominant Stargardt Macular Dystrophy (STGD3) and ELOVL4.
Logan S; Anderson RE
Adv Exp Med Biol; 2014; 801():447-53. PubMed ID: 24664730
[TBL] [Abstract][Full Text] [Related]
24. Novel Cellular Functions of Very Long Chain-Fatty Acids: Insight From ELOVL4 Mutations.
Deák F; Anderson RE; Fessler JL; Sherry DM
Front Cell Neurosci; 2019; 13():428. PubMed ID: 31616255
[TBL] [Abstract][Full Text] [Related]
25. Elovl4 5-bp deletion knock-in mouse model for Stargardt-like macular degeneration demonstrates accumulation of ELOVL4 and lipofuscin.
Vasireddy V; Jablonski MM; Khan NW; Wang XF; Sahu P; Sparrow JR; Ayyagari R
Exp Eye Res; 2009 Dec; 89(6):905-12. PubMed ID: 19682985
[TBL] [Abstract][Full Text] [Related]
26. In vivo effect of mutant ELOVL4 on the expression and function of wild-type ELOVL4.
Mandal NA; Tran JT; Zheng L; Wilkerson JL; Brush RS; McRae J; Agbaga MP; Zhang K; Petrukhin K; Ayyagari R; Anderson RE
Invest Ophthalmol Vis Sci; 2014 Apr; 55(4):2705-13. PubMed ID: 24644051
[TBL] [Abstract][Full Text] [Related]
27. Very long chain polyunsaturated fatty acids and rod cell structure and function.
Marchette LD; Sherry DM; Brush RS; Chan M; Wen Y; Wang J; Ash JD; Anderson RE; Mandal NA
Adv Exp Med Biol; 2014; 801():637-45. PubMed ID: 24664753
[TBL] [Abstract][Full Text] [Related]
28. Novel Approaches for Elongation of Fish Oils into Very-Long-Chain Polyunsaturated Fatty Acids and Their Enzymatic Interesterification into Glycerolipids.
Honzíková T; Agbaga MP; Anderson RE; Brush R; Ahmad M; Musílková L; Šejstalová K; Alishevich K; Beneš R; Šimicová P; Berčíková M; Filip V; Kyselka J
J Agric Food Chem; 2023 Nov; 71(46):17909-17923. PubMed ID: 37947776
[TBL] [Abstract][Full Text] [Related]
29. Identification and quantification of phosphatidylcholines containing very-long-chain polyunsaturated fatty acid in bovine and human retina using liquid chromatography/tandem mass spectrometry.
Berdeaux O; Juaneda P; Martine L; Cabaret S; Bretillon L; Acar N
J Chromatogr A; 2010 Dec; 1217(49):7738-48. PubMed ID: 21035124
[TBL] [Abstract][Full Text] [Related]
30. Endoplasmic reticulum microenvironment and conserved histidines govern ELOVL4 fatty acid elongase activity.
Logan S; Agbaga MP; Chan MD; Brush RS; Anderson RE
J Lipid Res; 2014 Apr; 55(4):698-708. PubMed ID: 24569140
[TBL] [Abstract][Full Text] [Related]
31. Role of Elovl4 protein in the biosynthesis of docosahexaenoic acid.
Agbaga MP; Brush RS; Mandal MN; Elliott MH; Al-Ubaidi MR; Anderson RE
Adv Exp Med Biol; 2010; 664():233-42. PubMed ID: 20238022
[TBL] [Abstract][Full Text] [Related]
32. Loss of functional ELOVL4 depletes very long-chain fatty acids (> or =C28) and the unique omega-O-acylceramides in skin leading to neonatal death.
Vasireddy V; Uchida Y; Salem N; Kim SY; Mandal MN; Reddy GB; Bodepudi R; Alderson NL; Brown JC; Hama H; Dlugosz A; Elias PM; Holleran WM; Ayyagari R
Hum Mol Genet; 2007 Mar; 16(5):471-82. PubMed ID: 17208947
[TBL] [Abstract][Full Text] [Related]
33. Stargardt Phenotype Associated With Two ELOVL4 Promoter Variants and ELOVL4 Downregulation: New Possible Perspective to Etiopathogenesis?
Donato L; Scimone C; Rinaldi C; Aragona P; Briuglia S; D'Ascola A; D'Angelo R; Sidoti A
Invest Ophthalmol Vis Sci; 2018 Feb; 59(2):843-857. PubMed ID: 29417145
[TBL] [Abstract][Full Text] [Related]
34. Polyunsaturated very-long-chain C28-C36 fatty acids and retinal physiology.
McMahon A; Kedzierski W
Br J Ophthalmol; 2010 Sep; 94(9):1127-32. PubMed ID: 19666930
[TBL] [Abstract][Full Text] [Related]
35. Haploinsufficiency is not the key mechanism of pathogenesis in a heterozygous Elovl4 knockout mouse model of STGD3 disease.
Raz-Prag D; Ayyagari R; Fariss RN; Mandal MN; Vasireddy V; Majchrzak S; Webber AL; Bush RA; Salem N; Petrukhin K; Sieving PA
Invest Ophthalmol Vis Sci; 2006 Aug; 47(8):3603-11. PubMed ID: 16877435
[TBL] [Abstract][Full Text] [Related]
36. Retinal very long-chain PUFAs: new insights from studies on ELOVL4 protein.
Agbaga MP; Mandal MN; Anderson RE
J Lipid Res; 2010 Jul; 51(7):1624-42. PubMed ID: 20299492
[TBL] [Abstract][Full Text] [Related]
37. Role of long-chain and very-long-chain polyunsaturated fatty acids in macular degenerations and dystrophies.
Liu A; Lin Y; Terry R; Nelson K; Bernstein PS
Clin Lipidol; 2011; 6(5):593-613. PubMed ID: 25324899
[TBL] [Abstract][Full Text] [Related]
38. Elovl4 haploinsufficiency does not induce early onset retinal degeneration in mice.
Li W; Chen Y; Cameron DJ; Wang C; Karan G; Yang Z; Zhao Y; Pearson E; Chen H; Deng C; Howes K; Zhang K
Vision Res; 2007 Mar; 47(5):714-22. PubMed ID: 17254625
[TBL] [Abstract][Full Text] [Related]
39. Retinal bioavailability and functional effects of a synthetic very-long-chain polyunsaturated fatty acid in mice.
Gorusupudi A; Rallabandi R; Li B; Arunkumar R; Blount JD; Rognon GT; Chang FY; Wade A; Lucas S; Conboy JC; Rainier JD; Bernstein PS
Proc Natl Acad Sci U S A; 2021 Feb; 118(6):. PubMed ID: 33526677
[TBL] [Abstract][Full Text] [Related]
40. Depletion of ceramides with very long chain fatty acids causes defective skin permeability barrier function, and neonatal lethality in ELOVL4 deficient mice.
Li W; Sandhoff R; Kono M; Zerfas P; Hoffmann V; Ding BC; Proia RL; Deng CX
Int J Biol Sci; 2007 Feb; 3(2):120-8. PubMed ID: 17311087
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
